Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)

NCT03465904 is registered in ClinicalTrials.gov with Cefaly Technology as lead sponsor.

NCT NCT03465904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03465904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Lead sponsor
Cefaly Technology
Phase
Not applicable
Overall status
Completed
Start date
April 10, 2018
Completion date
January 11, 2019
Enrollment
607 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

migraine